SMTL ID : 6hrp.1

CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 6-(dimethylamino)-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridyl]amino]-6-oxo-3-pyridyl]phenyl]-3,4-dihydroisoquinolin-1-one

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.12 Å

Oligo State

monomer

Ligands

1 x GMQ: 6-~{tert}-butyl-8-fluoranyl-2-[2-(hydroxymethyl)-3-[1-methyl-5-[(5-morpholin-4-ylcarbonylpyridin-2-yl)amino]-6-oxidanylidene-pyridazin-3-yl]phenyl]phthalazin-1-one(Non-covalent)

GMQ.1: 24 residues within 4Å: Chain A: L.32, G.33, T.34, G.35, F.37, V.40, A.52, K.54, T.98, E.99, Y.100, M.101, A.102, N.103, G.104, D.145, N.150, L.152, S.162, D.163, L.166, S.167, V.170, Y.175 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:F.37, A:V.40, A:V.40, A:V.40, A:Y.100, A:D.163, A:V.170, A:Y.175 Hydrogen bonds: A:K.54, A:M.101, A:M.101, A:S.162, A:S.162 Water bridges: A:G.35, A:C.105, A:R.114

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lopez-Tapia, F. et al., A potent seven-membered cyclic BTK (Bruton's tyrosine Kinase) chiral inhibitor conceived by structure-based drug design to lock its bioactive conformation. Bioorg.Med.Chem.Lett. (2019)

Release Date

2019-03-20

Peptides

Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence